Nardella Deanna, Canavan Maureen E, Taylor Sarah N, Sharifi Mona
Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut.
Yale Cancer Outcomes, Public Policy and Effectiveness Research Center, Yale School of Medicine, New Haven, Connecticut.
JAMA Netw Open. 2025 Jul 1;8(7):e2521902. doi: 10.1001/jamanetworkopen.2025.21902.
Hypertension contributes to US maternal-infant morbidity and mortality, with potential attenuation from breastfeeding. Little is known regarding breastfeeding outcomes among mother-infant dyads exposed to hypertensive disorders of pregnancy (HDP).
To quantify the extent to which HDP is associated with never breastfeeding and the time to breastfeeding cessation among postpartum women in the US.
DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used nationally representative data from the Centers for Disease Control and Prevention Pregnancy Risk Assessment Monitoring System (PRAMS). Participants included women from 43 US states, Washington, DC, and Puerto Rico who had a live birth between January 2016 and November 2022. Complete data for HDP exposure, outcomes of breastfeeding noninitiation or cessation, and all covariates were included in the analysis, performed from October to December 2024.
Self-reported high blood pressure or hypertension, preeclampsia, or eclampsia before or during pregnancy.
Odds of never breastfeeding, hazard of breastfeeding cessation, and median time to breastfeeding cessation, adjusted for sociodemographic and maternal-infant health covariates.
Of 205 247 women (weighted number, 10 915 302), mean (SD) age was 30.0 (5.8) years; 99.0% were first-time mothers; 54.0% had private and 40.0% had Medicaid insurance; and 91.0% delivered a term infant. HDP and breastfeeding initiation were reported by approximately 17.0% and 88.0% of women, respectively. Adjusting for covariates, HDP was associated with higher odds of never breastfeeding (adjusted odds ratio, 1.11; 95% CI, 1.05-1.18), and among those who breastfed, a higher adjusted hazard of breastfeeding cessation (adjusted hazard ratio, 1.17; 95% CI, 1.14-1.21). The median time to breastfeeding cessation among those with HDP was 17 weeks shorter than among those without HDP (unadjusted median duration, 17 [IQR, 5.0 to >46.7] vs 34 [IQR, 9.0 to >46.7] weeks).
In this cross-sectional study representing more than 10 million US postpartum women, HDP was associated with higher odds of never breastfeeding and a higher hazard of breastfeeding cessation. Studies to understand the potential mechanisms of this association are required to develop targeted breastfeeding support strategies for individuals with HDP.
高血压导致美国母婴发病和死亡,母乳喂养可能会减轻这种影响。对于患有妊娠高血压疾病(HDP)的母婴对的母乳喂养结果知之甚少。
量化在美国产后妇女中,HDP与从未进行母乳喂养以及母乳喂养停止时间之间的关联程度。
设计、设置和参与者:这项横断面研究使用了来自疾病控制和预防中心妊娠风险评估监测系统(PRAMS)的具有全国代表性的数据。参与者包括来自美国43个州、华盛顿特区和波多黎各的妇女,她们在2016年1月至2022年11月期间有活产。将HDP暴露、母乳喂养未开始或停止的结果以及所有协变量的完整数据纳入2024年10月至12月进行的分析。
自我报告的孕前或孕期高血压或子痫前期或子痫。
从未进行母乳喂养的几率、母乳喂养停止的风险以及母乳喂养停止的中位时间,并根据社会人口统计学和母婴健康协变量进行调整。
在205247名妇女(加权人数为10915302)中,平均(标准差)年龄为30.0(5.8)岁;99.0%为初产妇;54.0%有私人保险,40.0%有医疗补助保险;91.0%分娩的是足月儿。分别约有17.0%和88.0%的妇女报告患有HDP和开始母乳喂养。在调整协变量后,HDP与从未进行母乳喂养的较高几率相关(调整后的优势比为1.11;95%置信区间为1.05-1.18),并且在进行母乳喂养的妇女中,母乳喂养停止的调整后风险较高(调整后的风险比为1.17;95%置信区间为1.14-1.21)。患有HDP的妇女母乳喂养停止的中位时间比未患有HDP的妇女短17周(未调整的中位持续时间分别为17[四分位间距,5.0至>46.7]周和34[四分位间距,9.0至>46.7]周)。
在这项代表超过1000万美国产后妇女的横断面研究中,HDP与从未进行母乳喂养的较高几率以及母乳喂养停止的较高风险相关。需要开展研究以了解这种关联的潜在机制,从而为患有HDP的个体制定有针对性的母乳喂养支持策略。